Active substance
Racecadotril
- SFDA 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| HIDRASEC | 100 mg | Capsule, hard · Oral use | 10 Blister | SAR 21.19 | NCE · Prescription | Abbott Laboratories GmbH | Valid |
| HIDRASEC | 30 mg | Granules for oral suspension · Oral use | 16 Sachet | SAR 31.24 | NCE · Prescription | Abbott Laboratories GmbH | Valid |
| HIDRASEC | 10 mg | Granules for oral suspension · Oral use | 16 Sachet | SAR 32.10 | NCE · Prescription | Abbott Laboratories GmbH | Valid |
| Racad | 30 mg | Granules for oral suspension · Oral use | 16 Sachet | SAR 29.15 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| Racad | 10 mg | Granules for oral suspension · Oral use | 16 Sachet | SAR 29.95 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
Indications — CHI Daman Drug Formulary
DIARRHEA
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.